Discover New Paths in Chronic Liver Disease Regenerative Care

Why Chronic Liver Disease Needs a New Approach?

Chronic liver disease is not about just slowing damage- at present, regenerative science is rewriting the narrative. 

Chronic Liver Disease (CLD), or ‘Liver Cirrhosis’, is characterized by scarred liver tissue. It compromises normal liver functioning. The liver damage builds up over time. Globally, more than 2 million deaths occur annually and 11th leading cause of mortality. 1 out of 3 deaths occurs among females [1]. The global burden of disease is increasing gradually, and the current treatment focuses on management. 

The treatment needs to shift towards a regenerative approach as symptom-based management cannot reverse fibrosis or restore lost liver function.

Ask The Expert

What Is Chronic Liver Disease?

CLD is late stage liver disease that progresses in > 6 months of liver injury. The scarring of liver tissue occurs with long-term inflammation in the liver (hepatitis). The scarring progression compromises liver function and leads to liver failure. The includes:

• Waste excretion from the body (toxins or medication)
• Bile production (digestive enzyme)
• Stores sugar for energy
• Protein synthesis (albumin, clotting factors)
• Role in immune surveillance

What are Chronic Liver Disease Causes?

CLD is triggered by liver inflammation. The conditions that lead to liver inflammation potentially cause cirrhosis. Chronic liver disease is subcategorized under alcohol-related liver disease and Non-alcoholic fatty liver disease (NAFLD/NASH). These are as follows: 

1. Alcohol-Related Liver Disease: Long-term alcohol use, accumulation of toxic by-products, and promotion of inflammation in liver cells. This is a common well-known factor leading to liver cirrhosis.
2. Non-Alcoholic Fatty Liver Disease (NAFLD/NASH): The common non-alcohol factors include: 

• Metabolic Dysfunction-Associated Steatohepatitis (MASH): Excessive fat storage in the liver, associated with metabolic disorders such as hyperlipidemia, hyperglycemia, hyperlipidemia. 
• Viral Hepatitis (B & C): Hepatitis B and C infection remains in a dormant form, i.e. most of the individuals do not realise it till the late stage.
• Autoimmune Disease:  Autoimmune conditions like primary biliary cholangitis, hepatitis, and sclerosing cholangitis are common factors that lead to liver inflammation.  
• Genetic Predisposition: Inherited conditions (glycogen storage condition, Wilson disease, cystic fibrosis) supports buildup of toxins in the liver
• Toxic Exposure: Long-term exposure to environmental toxins or medication (NSAIDs) promotes liver damage
• Cardiovascular Condition: congestive heart failure (blood buildup in the liver), chronic ischemia (prevents blood from reaching the liver)

Chronic Liver Disease Symptoms: Early vs Late Stage

There are various signs and symptoms of chronic liver disease. These are subcategorized as:

• Early: Fatigue, appetite loss, mild abdominal discomfort, Pain in the upper abdomen
• Progressive: Jaundice, oedema, ascites (fluid buildup in abdomen), visible blood vessels that look like spiders, itchy skin (no visible rash)
• Advanced: Easy bleeding or brushing tendency, confusion (hepatic encephalopathy), irregular menstrual cycles

What are the Chronic Liver Disease Stages?

The CDL stages include:

• Stage 1: Inflammation (swelling in liver tissue)
• Stage 2: Fibrosis (untreated inflamed liver, scarring begins)
• Stage 3: Cirrhosis (irreversible scarring)
• Stage 4: End-stage liver disease (liver function ceased)

How Chronic Liver Disease Is Diagnosed?

The common diagnosis for CLD includes: 

• Liver function tests (ALT, AST, bilirubin, albumin)
• Imaging (Ultrasound, FibroScan, MRI)
• Liver biopsy
• Detection of Non-invasive Fibrosis Markers

What is Conventional Liver Disease Treatment?

Cirrhosis is permanent liver scarring, which cannot be reversed or cured. Conventional treatment focuses on symptom management. This includes: 

• Palliative Care: Different medications are prescribed depending on the cause. For example: Antivirals for managing Hepatitis C and B virus, Corticosteroids and Immunosuppressants for autoimmune disease
• Lifestyle Modification: Alcohol cessation, elimination of toxin exposure, management of substance
• Metabolic Disorder Management: factors like high blood sugar, blood pressure or cholesterol\
• Complication Management: Sclerotherapy (seal bleeding veins), paracentesis (removal of fluid buildup), blood transfusion, and kidney dialysis
• Liver Transplantation: At the most advanced stage healthcare provider recommends liver transplantations

The above treatments are inefficient in reversing liver damage. There is significant scope in research and adaptation of regenerative approaches that can potentially reverse scarring.

How Regenerative Medicine Is Changing Liver Disease Treatment?

The emergence of regenerative treatment promises the liver’s natural ability to regenerate. The transformation is going beyond symptomatic care. This enables regeneration of liver cells/tissue, repair of damaged cells, or replacing the scarred cells. Stem cell therapy is the most popular approach that potentially aids in scarred tissue regeneration.

How Stem Cell Therapy in Chronic Liver Disease Works?

Research highlighted the potential of Mesenchymal Stem Cells (MSCs) in regenerative therapy. Stem cells are specialized cells that bring about changes from within. They undertake multiple unique mechanisms of action, including:

• Regeneration/Repair: MSCs are multipotent and differentiate into specific cell types, including hepatocytes. They release various growth factors, cytokines, transcription factors, and extracellular matrix molecules that aid in liver cell regeneration and repair. 
• Anti-Inflammation: MSCs release anti-inflammatory molecules and introduce antioxidants, modulating energy metabolism in liver injury
• Anti-Fibrotic: MSCs ameliorate liver fibrosis, which improves liver function 
• Immunomodulation: MSCs reduce immune cell infiltration and hepatocyte apoptosis. They induce paracrine signalling (HGF, IDO, TGF-β) that shows immunosuppressive effects. The administration of stem cell therapy with liver transplantation creates a supportive environment.

What does Preclinical and Clinical Evidence State About Regenerative Liver Care?

Stem cells for liver regeneration have shown positive outcomes. This includes:

• Independent trials have shown safety and efficacy in intravenous treatment. 
• Significantly improvement in liver function, reduced comorbidities and associated mortality. 
• MSCs promote hepatocyte proliferation and create a supportive microenvironment for the survival of existing cells/tissues.
• In the viral infection model, MSCs have shown potential in treating hepatic fibrosis [2].

What are the Key Challenges in Regenerative Liver Care?

• Monitoring treatment effectiveness for long-term
• Lack of large-scale clinical trial outcomes for determining long-term safety and efficacy
• Standardization of treatment protocol and cell sourcing

What is the Key Focus in Regenerative Liver Care?

Chronic liver disease is complex and difficult to treat, but stem cells have provided an effective solution path. However, promising, currently, stem cell therapy for hepatic insufficiency requires stringent, comprehensive research. Researchers and clinicians focus on developing effective monitoring solutions, treatment standardization, and regulations.

*Advancells, India, is working on cutting-edge research based on stem cells against various chronic diseases. The laboratory is among India’s most renowned centres that are GMP certified and follow stringent regulations in isolation, culture, and maintenance of clinical-grade stem cells. 

Chronic Liver Disease Patient Success Stories

Conclusion: A New Era in Chronic Liver Disease Care

The transformation from irreversible damage to a regenerative approach is hoped for in Liver Disease Treatment. Early intervention is the key to the most effective treatment and success. The combination of conventional therapy and regenerative approach is a sustainable path in developing better patient outcomes. 

References

1. Devarbhavi H, Asrani SK, Arab JP, Nartey YA, Pose E, Kamath PS. Global burden of liver disease: 2023 update. Journal of hepatology. 2023 Aug 1;79(2):516-37.
2. Bozorgi V, Babaahmadi M, Salehi M, Vafaeimanesh J, Hajizadeh-Saffar E. From signaling pathways to clinical trials: mesenchymal stem cells as multimodal regenerative architects in liver cirrhosis therapy. Stem Cell Research & Therapy. 2025 Aug 5;16(1):421.

FAQ’s

Q- What are Common Liver Disease Symptoms? 

Common liver disease symptoms include jaundice, abdominal issues, fatigue, skin changes, digestive discomfort, brushing or bleeding. In the advanced stage, the symptoms include respiratory issues, swelling, muscle loss, confusion or memory loss.

Q- What are Stem Cells for Liver Disease?

MSCs are most commonly used for liver disease. The cells have shown potential in regeneration, immunomodulation, and anti-inflammation. They create a supportive microenvironment that prevents further liver cell damage.

Q- Who Can OPT for Stem Cell Therapy for Chronic Liver Disease?

The suitability of the patient is determined after a detailed health assessment. This includes consideration of overall health, severity, progression, and other health parameters. In the presence of certain comorbidities such as cancer, infection, or end-stage liver damage, a patient might not qualify for the stem cell treatment.